v.salgado
TL2 Moderator · Konya
Contributes reviews on supplier material. Based in Konya.
Joined 8 September 2025 · last posted 4d
83 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #81 · Compounds › Cagrilintide & amylin analogues · 24 Jul 2026 · 2 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Does a peptide degrade silently, with no visual change? Replied, post #76 · Practice › Storage & stability · 22 Jul 2026 · 21 likes I read post #74 twice before replying, because I had assumed the opposite. Container choice matters: the material of the vial, the rubber closure, the fill volume all…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #98 · Start Here › Welcome · 21 Jul 2026 · 0 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Seven-day rolling means and why weekly readings mislead Replied, post #28 · Outcomes › Progress reports · 14 Jul 2026 · 16 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #56 · Nutrition & Training › Protein & intake · 12 Jul 2026 · 1 like On post #52 — agreed on the reasoning, with one qualification. Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients…
-
CJC-1295 with and without DAC: what the modification does Replied, post #109 · Compounds › Secretagogues & GH axis · 11 Jul 2026 · 0 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #73 · Start Here › Welcome · 10 Jul 2026 · 8 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
What to include when your question involves a chromatogram — one year on Replied, post #60 · Start Here › How to Ask · 2 Jul 2026 · 29 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Aggregate verification data across the directory, with caveats Replied, post #6 · Sourcing › Independent verification · 20 Jun 2026 · 0 likes I read post #4 twice before replying, because I had assumed the opposite. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #45 · Evidence › Journal club · 19 Jun 2026 · 5 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #9 · marked as the solution · Access › Shortages · 4 Jun 2026 · 7 likes post #8 is right about the mechanism and I think understates the practical bit. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #29 · Practice › Dosing & titration · 18 May 2026 · 7 likes On post #25 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Official shortage notices and what they authorise Replied, post #53 · Access › Shortages · 16 May 2026 · 10 likes Worth separating two things that post #49 runs together. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the…
-
Cold solution and stinging: the simplest fix Replied, post #25 · Practice › Administration · 14 May 2026 · 12 likes Picking up post #22: that is the part I would want checked first. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #6 · Evidence › Trials · 6 May 2026 · 32 likes Worth separating two things that post #2 runs together. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it…
-
About the COA interpretation category Replied, post #10 · Analytics › COA interpretation · 1 May 2026 · 9 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Reading a home test result without over-claiming Replied, post #25 · Analytics › Home & field testing · 28 Apr 2026 · 7 likes Coming back to post #23, because the follow-up matters more than the original answer. Colorimetric tests: colour intensity correlates with concentration, but the…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #89 · Practice › Reconstitution · 23 Apr 2026 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Journal club: is percentage weight change the right endpoint? Replied, post #75 · Evidence › Journal club · 17 Apr 2026 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #76 · Compounds › Tirzepatide · 9 Apr 2026 · 0 likes I read post #74 twice before replying, because I had assumed the opposite. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much…
-
Semaglutide formulation: what is in the licensed product besides the peptide Started this topic · Compounds › Semaglutide · 5 Apr 2026 · 4 likes Semaglutide formulation: what is in the licensed product besides the peptide — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #95 · Analytics › Mass spectrometry · 4 Apr 2026 · 24 likes Worth separating two things that post #91 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
GLP-1 receptor distribution: central and peripheral Replied, post #24 · Pharmacology › Receptor biology · 31 Mar 2026 · 13 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #45 · Outcomes › Body composition · 21 Mar 2026 · 6 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Solubility limits and what a cloudy solution is telling you Replied, post #5 · Pharmacology › Formulation chemistry · 14 Mar 2026 · 27 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #42 · Lounge › Introductions · 12 Mar 2026 · 0 likes Worth separating two things that post #38 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #64 · Outcomes › Body composition · 7 Mar 2026 · 1 like post #63 answers the question as asked. The question underneath it is different. Visceral fat: DXA does not distinguish visceral (organ-associated) fat from…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #5 · Pharmacology › Formulation chemistry · 26 Feb 2026 · 1 like Fill volume and headspace: the amount of solution in a vial and the air above it affect how much the solution is exposed to oxygen during storage. Less headspace means…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #80 · Meta › Site feedback · 23 Feb 2026 · 11 likes Coming back to post #78, because the follow-up matters more than the original answer. Accessibility: screen readers, keyboard navigation, contrast, font size — if…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #103 · Practice › Dosing & titration · 20 Feb 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #63 · Analytics › Mass spectrometry · 14 Feb 2026 · 17 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #14 · Practice › Interactions · 5 Feb 2026 · 16 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Trifluoroacetate content and its consequences Replied, post #52 · Analytics › Impurities & related substances · 31 Jan 2026 · 0 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #38 · Documentation › Wiki requests · 14 Jan 2026 · 32 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #7 · Compounds › Secretagogues & GH axis · 5 Jan 2026 · 17 likes This follows post #4 rather than contradicting it. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #31 · Practice › Dosing & titration · 22 Dec 2025 · 5 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Second pass at: Temperature logging at home: what is worth the effort Started this topic · Practice › Storage & stability · 14 Dec 2025 · 12 likes Posting this under the heading it deserves: Second pass at: Temperature logging at home: what is worth the effort Everything below is what sits behind that. Reporting…
-
[2026 update] What steady state means for the decision to escalate Replied, post #117 · Practice › Dosing & titration · 17 Nov 2025 · 7 likes I read post #115 twice before replying, because I had assumed the opposite. Titrating on tolerability rather than on the calendar: some people escalate when they…
-
Lurking for two months before posting: was that the right call? Replied, post #4 · Start Here › Welcome · 16 Nov 2025 · 1 like The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #21 · Meta › Announcements · 10 Nov 2025 · 21 likes This follows post #18 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Availability by country, dated, with primary sources Replied, post #34 · Access › International · 26 Oct 2025 · 19 likes post #33 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
New subcategory: rationale and scope Replied, post #52 · Meta › Announcements · 18 Oct 2025 · 24 likes post #51 is right about the mechanism and I think understates the practical bit. Implementation timeline: announcements include when a change takes effect. Marking the…
-
Titles that describe the question, not the situation Replied, post #101 · Start Here › How to Ask · 20 Sep 2025 · 0 likes This follows post #98 rather than contradicting it. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three…
-
Reading SURMOUNT-1 without the press release Replied, post #11 · Compounds › Tirzepatide · 18 Sep 2025 · 6 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #84 · Compounds › Secretagogues & GH axis · 21 Aug 2025 · 0 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #7 · Documentation › Doc review · 18 Aug 2025 · 2 likes Worth separating two things that post #3 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
A request that was declined, and the reasoning — a second dataset Replied, post #59 · Documentation › Wiki requests · 12 Aug 2025 · 0 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
-
Counter-ion content and its effect on measured mass Replied, post #107 · Analytics › Mass spectrometry · 30 Jul 2025 · 6 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
An appeal that failed, and what I would do differently Replied, post #8 · Access › Insurance & coverage · 21 Jul 2025 · 13 likes This follows post #5 rather than contradicting it. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers…
-
[2026 update] Splitting an overlong document into two Replied, post #15 · Documentation › Wiki requests · 8 Jul 2025 · 4 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #17 · Practice › Administration · 29 Jun 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Sequence verification for an obscure compound: how it is done Replied, post #73 · Compounds › Other compounds · 25 Jun 2025 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Revisiting: What to include when your question involves arithmetic Replied, post #6 · Start Here › How to Ask · 24 Jun 2025 · 20 likes Picking up post #3: that is the part I would want checked first. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #61 · Devices › Pens & autoinjectors · 8 Jun 2025 · 12 likes I read post #59 twice before replying, because I had assumed the opposite. Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #116 · Devices › Cold chain · 4 Jun 2025 · 0 likes post #115 answers the question as asked. The question underneath it is different. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #17 · Clinical › Bloodwork · 9 May 2025 · 0 likes Worth separating two things that post #13 runs together. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more…
-
Lean mass preservation: what the evidence supports Replied, post #8 · Outcomes › Body composition · 8 May 2025 · 0 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #93 · Compounds › Semaglutide · 27 Apr 2025 · 0 likes Coming back to post #91, because the follow-up matters more than the original answer. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly…
-
Criticising the method without criticising the authors Replied, post #53 · Evidence › Study critique · 5 Apr 2025 · 22 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #84 · Documentation › Doc review · 1 Apr 2025 · 0 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #54 · Compounds › Secretagogues & GH axis · 28 Mar 2025 · 0 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Albumin binding and how it produces a long half-life Replied, post #16 · Pharmacology › Pharmacokinetics · 20 Mar 2025 · 3 likes Coming back to post #14, because the follow-up matters more than the original answer. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days.…
-
Reading order for a first week here, and what to skip until later Replied, post #43 · Start Here › Welcome · 19 Mar 2025 · 3 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #69 · Sourcing › Regulatory · 2 Mar 2025 · 1 like Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Protein density versus volume when you cannot eat much Replied, post #93 · Nutrition & Training › Protein & intake · 8 Feb 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #21 · Access › International · 31 Jan 2025 · 9 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Follow-up: Individual participant data versus aggregate data Replied, post #69 · Evidence › Meta-analyses · 10 Jan 2025 · 30 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What we do not know about retatrutide, listed explicitly Replied, post #49 · Compounds › Retatrutide · 9 Jan 2025 · 1 like Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Second pass at: Albumin binding and how it produces a long half-life Replied, post #9 · Pharmacology › Pharmacokinetics · 7 Jan 2025 · 4 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #150 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Body image changing more slowly than the body Replied, post #98 · Wellbeing › Mental health · 22 Dec 2024 · 32 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
Body image changing more slowly than the body Replied, post #73 · Wellbeing › Mental health · 19 Dec 2024 · 20 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
-
[2026 update] New subcategory: rationale and scope Replied, post #55 · Meta › Announcements · 10 Dec 2024 · 0 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
EMA product information as a primary source — does this still hold? Replied, post #110 · Regional › European Union · 18 Nov 2024 · 10 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
-
EMA product information as a primary source — does this still hold? Replied, post #98 · Regional › European Union · 17 Nov 2024 · 0 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
-
When to suspect the method rather than the sample Replied, post #30 · Analytics › Method validation · 30 Oct 2024 · 11 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #73 · Analytics › COA interpretation · 3 Oct 2024 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #6 · Start Here › Welcome · 12 Sep 2024 · 0 likes This follows post #3 rather than contradicting it. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #34 · Evidence › Preprints · 5 Sep 2024 · 27 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #49 · Nutrition & Training › Hydration & electrolytes · 20 Aug 2024 · 0 likes I read post #47 twice before replying, because I had assumed the opposite. Exercise and electrolyte losses: sweating during exercise increases sodium and potassium…
-
Naming conventions for research peptides and the confusion they cause — one year on Replied, post #3 · Compounds › Other compounds · 17 Jul 2024 · 32 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Journal club: FLOW and the renal composite, component by component Replied, post #59 · Evidence › Journal club · 14 Jul 2024 · 28 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #24 · Practice › Dosing & titration · 18 Jun 2024 · 1 like I read post #22 twice before replying, because I had assumed the opposite. Steady state means the plasma concentration is stable from dose to dose. That happens around…